Literature DB >> 2370922

Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.

H Schmitt1, A Bohle, T Reineke, D Mayer-Eichberger, W Vogl.   

Abstract

We carried out a retrospective investigation in 220 patients to assess the influence of various parameters on the long-term course of membranoproliferative glomerulonephritis (MPGN) type I. 50 patients (23%) died during the follow-up period of 59 months on average, in another 57 (26%) end-stage renal failure developed. 54 patients (24%) suffered from chronic renal failure, stable renal function (creatinine below 1.3 mg/dl) was preserved in 59 patients (27%). 5 years after biopsy 49% of the patients had already died or needed regular dialysis treatment; after 10 years this proportion increased to 64%. Morphological findings: The outcome was--with the exception of focal crescent formations--not determined by the severity of glomerular changes; the survival rate, however, decreased significantly, if tubulointerstitial lesions were present as defined by acute renal failure, interstitial fibrosis or a combination of both. Clinical parameters: A progressive deterioration of renal function and an increasing number of renal deaths was noticed, when elevated serum creatinine levels at the time of biopsy and high blood pressure values during the follow-up period were observed. 26 patients died from hypertension, 18 of whom before reaching end-stage renal failure. Nephrotic syndrome and the degree of proteinuria as well as antiphlogistic and immunosuppressive treatment did not influence the prognosis of MPGN type I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370922     DOI: 10.1159/000185969

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1.

Authors:  Y Kawasaki; J Suzuki; R Nozawa; H Suzuki
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

Review 2.  De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature.

Authors:  Anuja Java; Joseph P Gaut; Daniel C Brennan
Journal:  Transpl Int       Date:  2012-03-01       Impact factor: 3.782

3.  Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.

Authors:  Takashi Takei; Mitsuyo Itabashi; Takahito Moriyama; Ari Shimizu; Yuki Tsuruta; Ayami Ochi; Kayu Nakayama; Chihiro Iwasaki; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-07-21       Impact factor: 2.801

4.  The significance of tubulointerstitial lesions in childhood Henoch-Schönlein nephritis.

Authors:  Beom Jin Lim; Jae Il Shin; Sung-Eun Choi; Hyechang Rhim; Jae Seung Lee; Pyung Kil Kim; Hyeon Joo Jeong; Ji Hong Kim
Journal:  Pediatr Nephrol       Date:  2016-05-27       Impact factor: 3.714

5.  Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Authors:  Paraskevas Iatropoulos; Erica Daina; Manuela Curreri; Rossella Piras; Elisabetta Valoti; Caterina Mele; Elena Bresin; Sara Gamba; Marta Alberti; Matteo Breno; Annalisa Perna; Serena Bettoni; Ettore Sabadini; Luisa Murer; Marina Vivarelli; Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

6.  Familial C4B deficiency and immune complex glomerulonephritis.

Authors:  K Soto; Y L Wu; A Ortiz; S R Aparício; C Y Yu
Journal:  Clin Immunol       Date:  2010-07-02       Impact factor: 3.969

7.  Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.

Authors:  O Harmankaya; T Baştürk; Y Oztürk; N Karabiber; A Obek
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.

Authors:  Andrea B Kramer; Mirjan M van Timmeren; Theo A Schuurs; Vishal S Vaidya; Joseph V Bonventre; Harry van Goor; Gerjan Navis
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-18

9.  Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  M Somers; S Kertesz; S Rosen; J Herrin; R Colvin; N Palacios de Carreta; M Kim
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

10.  Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.

Authors:  J M Bergstein; S P Andreoli
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.